171 related articles for article (PubMed ID: 30635211)
1. Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.
Lee GC; Ferrone CR; Vagefi PA; Uppot RN; Tanabe KK; Lillemoe KD; Blaszkowsky LS; Qadan M
Am J Surg; 2019 Jul; 218(1):157-163. PubMed ID: 30635211
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
Uhlig J; Sellers CM; Stein SM; Kim HS
Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.
Miura JT; Johnston FM; Tsai S; Eastwood D; Banerjee A; Christians KK; Turaga KK; Gamblin TC
HPB (Oxford); 2015 Oct; 17(10):896-901. PubMed ID: 26228076
[TBL] [Abstract][Full Text] [Related]
4. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
5. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
[TBL] [Abstract][Full Text] [Related]
6. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma.
Kutlu OC; Chan JA; Aloia TA; Chun YS; Kaseb AO; Passot G; Yamashita S; Vauthey JN; Conrad C
Cancer; 2017 May; 123(10):1817-1827. PubMed ID: 28085184
[TBL] [Abstract][Full Text] [Related]
8. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
Mironov O; Jaberi A; Kachura JR
J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis.
Kamarajah SK
Asian J Surg; 2018 Nov; 41(6):551-561. PubMed ID: 29454570
[TBL] [Abstract][Full Text] [Related]
11. Thermal ablation versus wedge or segmental resection in patients with early stage hepatocellular carcinoma: a population survival analysis.
Kolarich AR; Cabrera R; Hughes SJ; George TJ; Geller BS; Grajo JR
HPB (Oxford); 2019 Feb; 21(2):249-257. PubMed ID: 30057124
[TBL] [Abstract][Full Text] [Related]
12. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
13. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
14. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
[TBL] [Abstract][Full Text] [Related]
16. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
[TBL] [Abstract][Full Text] [Related]
17. Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
He W; Li B; Zheng Y; Zou R; Shen J; Cheng D; Tao Q; Liu W; Li Q; Chen G; Yuan Y
Liver Int; 2016 Nov; 36(11):1677-1687. PubMed ID: 27187721
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
20. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience.
Zhang T; Zeng Y; Huang J; Liao M; Wu H
J Surg Res; 2014 Oct; 191(2):370-8. PubMed ID: 24766727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
